Skip to main content
SpringerLink
Log in

Psychopharmaka in Schwangerschaft und Stillzeit

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie

  • 4955 Accesses

Zusammenfassung

Berücksichtigt werden hier Psychopharmaka im engeren Sinne und die Suchtund Substitutionsmittel, nicht aber die in den ► Kap. 7, ► Kap. 8, ► Kap. 9 und ► Kap. 10 beschriebenen Pharmaka.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bellantuono C, Tofani S, Di Sciascio G, Santone G (2013) Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. Gen Hosp Psychiatry 35(1): 3–8

    Article  PubMed  Google Scholar 

  • Brunner E, Falk DM, Jones M et al (2013) Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance. BMC Pharmacol Toxicol 14: 38

    Article  Google Scholar 

  • Campbell E, Kennedy F, Russell A et al (2014) Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2013-306318 (Epub ahead of print)

    PubMed  Google Scholar 

  • Deiana V, Chillotti C, Manchia M et al (2014) Continuation versus discontinuation of lithium during pregnancy: a retrospective case series. J Clin Psychopharmacol 34(3): 407–410

    Article  PubMed  Google Scholar 

  • Gentile S (2014) Tricyclic antidepressants in pregnancy and puerperium. Expert Opin Drug Saf 13(2): 207–225

    Article  CAS  PubMed  Google Scholar 

  • Grigoriadis S, Vonderporten EH, Mamisashvili L et al (2014) Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ 348:f6932

    Google Scholar 

  • Habermann F, Fritzsche J, Fuhlbrück F et al (2013) Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol 33(4): 453–462

    Article  CAS  PubMed  Google Scholar 

  • Huybrechts KF, Palmsten K, Avorn J et al (2014) Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 370: 2397–2407

    Article  CAS  PubMed  Google Scholar 

  • Jensen HM, Grøn R, Lidegaard Ø et al (2013) Maternal depression, antidepressant use in pregnancy and Apgar scores in infants. Br J Psychiatry 202(5): 347–351

    Article  PubMed  Google Scholar 

  • Jimenez-Solem E, Andersen JT, Petersen M et al (2013) SSRI use during pregnancy and risk of stillbirth and neonatal mortality. Am J Psychiatry 170(3): 299–304

    Article  PubMed  Google Scholar 

  • Kieler H, Artama M, Engeland A et al (2012) Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 344: d8012

    Google Scholar 

  • Klinger G, Stahl B, Fusar-Poli P, Merlob P (2013) Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev 10(3): 308–317

    PubMed  Google Scholar 

  • Larrimer MB, Dajani NK, Siegel ER et al (2014) Antiemetic medications in pregnancy: a prospective investigation of obstetric and neurobehavioral outcomes. Am J Obstet Gynecol 210(3): 270.e1–7

    Google Scholar 

  • Leiknes KA, Cooke MJ, Jarosch-von Schweder L et al (2013) Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Womens Ment Health (Epub ahead of print)

    Google Scholar 

  • Minozzi S, Amato L, Bellisario C et al (2013) Maintenance agonist treatments for opiatedependent pregnant women. Cochrane Database Syst Rev 12: CD006318

    Google Scholar 

  • Polen KN, Rasmussen SA, Riehle-Colarusso T, Reefhuis J; National Birth Defects Prevention Study (2013) Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007. Birth Defects Res A Clin Mol Teratol 97(1): 28–35

    Article  CAS  PubMed  Google Scholar 

  • Ross LE, Grigoriadis S, Mamisashvili L et al (2013) Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 70(4): 436–443

    Article  PubMed  Google Scholar 

  • Thyagarajan V, Robin Clifford C, Wurst KE et al (2012) Bupropion therapy in pregnancy and the occurrence of cardiovascular malformations in infants. Pharmacoepidemiol Drug Saf 21(11): 1240–1242

    Article  CAS  PubMed  Google Scholar 

  • van der Lugt NM, van de Maat JS, van Kamp IL et al (2012) Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies. Early Hum Dev 88(6): 375–378

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mainz

    O. Benkert

Authors
  1. O. Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Benkert, O. (2015). Psychopharmaka in Schwangerschaft und Stillzeit. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54769-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54769-0_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54768-3

  • Online ISBN: 978-3-642-54769-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation